From PBS Terra.

The allure of Theranos was its claim to detect numerous diseases from just a drop of blood.
While Elizabeth Holmes’ ambitions ended in scandal, the science she was pursuing wasn’t
entirely fantasy. Tina dives deep into the challenges of bloodwork, the technologies like mass
spectrometry that could someday make Theranos’ dream a reality, and introduces us to Iollo, a
new company promising what Theranos couldn’t deliver.

Dr. Tina Lasisi breaks down the story.

.
Original Production Funding Provided by National Science Foundation – Grant No. 2120006 Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation